Tumor antigens for prevention and/or treatment of cancer
US8207314B2 · kind B2 · utility
13Cited by
17References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 2004 |
| Grant date | Jun 26, 2012 |
| Priority date | — |
| Expiry date | Jan 29, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.